These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10519937)

  • 1. Immunization of dogs with a DNA vaccine induces protection against rabies virus.
    Perrin P; Jacob Y; Aguilar-Sétien A; Loza-Rubio E; Jallet C; Desmézières E; Aubert M; Cliquet F; Tordo N
    Vaccine; 1999 Oct; 18(5-6):479-86. PubMed ID: 10519937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
    Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC
    Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.
    Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L
    Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based immunization against Lyssaviruses.
    Perrin P; Jacob Y; Tordo N
    Intervirology; 2000; 43(4-6):302-11. PubMed ID: 11251386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
    Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
    Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant human adenovirus vaccine against rabies.
    Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
    J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P; Jacob Y; Desmézières E; Tordo N
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses.
    Bahloul C; Jacob Y; Tordo N; Perrin P
    Vaccine; 1998 Feb; 16(4):417-25. PubMed ID: 9607065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies: epidemiological tendencies and control tools.
    Tordo N; Bahloul C; Jacob Y; Jallet C; Perrin P; Badrane H
    Dev Biol (Basel); 2006; 125():3-13. PubMed ID: 16878455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization protects nonhuman primates against rabies virus.
    Lodmell DL; Ray NB; Parnell MJ; Ewalt LC; Hanlon CA; Shaddock JH; Sanderlin DS; Rupprecht CE
    Nat Med; 1998 Aug; 4(8):949-52. PubMed ID: 9701249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.
    Montaño-Hirose JA; Lafage M; Weber P; Badrane H; Tordo N; Lafon M
    Vaccine; 1993 Sep; 11(12):1259-66. PubMed ID: 8256507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.
    Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC
    Viruses; 2021 May; 13(5):. PubMed ID: 34065574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.